Literature DB >> 11070188

Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain.

Y Ibata1, N Iijima, Y Kataoka, K Kakihara, M Tanaka, M Hosoya, S Hinuma.   

Abstract

The gene of prolactin-releasing peptide (PrRP) was first cloned in 1998 and preproproteins encoded by cDNAs produced at least two isoforms of PrRP with different lengths; PrRP31 and PrRP20. PrRP has been shown to release prolactin from the anterior pituitary at least in vitro (Hinuma, Y.S., Habata, Y., Fuji, R., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., Sekiguchi, M., Kurokawa, T., Nishimura, O., Onda, H., and Fujino, A., 1998. A prolactin-releasing peptide in the brain. Nature 393, 272-6). PrRP receptor has also been detected by quantitive reverse transcription polymerase chain reaction, and in situ hybridization histochernistry revealed that expression of PrRP receptor mRNA was found in the broad areas of the brain and in the anterior pituitary of the rat. This review surveys morphological studies on PrRP, PrRP mRNA and PrRP receptor mRNA in the rat brain and discusses the possible functional significance of PrRP in the brain. PrRP immunoreactive neuronal perikarya showed a similar distributional pattern to those with PrRP mRNA signals. However, distribution of nerve processes and terminals with PrRP immunoreactivity was broadly expanded in the forebrain and brainstem. They were hardly detected in the median eminence particularly in its external layer. PrRP receptor mRNA signals were distributed in the preoptic area, and the hypothalamic area, where PrRP immunoreactive nerve processes and terminals were also detected. The strongest signal of PrRP receptor mRNA was detected in the reticular nucleus of the thalamus where neither PrRP immunoreactive nerve processes nor axon terminals were distributed. From the distribution pattern of PrRP and its receptor, it is suggested that PrRP is involved in control of secretion of oxytocin, corticotropin releasing hormone and somatostatin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070188     DOI: 10.1016/s0168-0102(00)00182-6

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  15 in total

1.  The hindbrain is a site of energy balance action for prolactin-releasing peptide: feeding and thermic effects from GPR10 stimulation of the nucleus tractus solitarius/area postrema.

Authors:  X S Davis; H J Grill
Journal:  Psychopharmacology (Berl)       Date:  2018-05-23       Impact factor: 4.530

2.  Study of the role of novel RF-amide neuropeptides in affecting growth hormone secretion in a representative non-human primate (Macaca mulatta).

Authors:  Fatima Qaiser; Fazal Wahab; Muhammad Amin Wiqar; Rizwan Hashim; Jerome Leprince; Hubert Vaudry; Manuel Tena-Sempere; Muhammad Shahab
Journal:  Endocrine       Date:  2012-04-22       Impact factor: 3.633

3.  Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.

Authors:  L Maletínská; V Nagelová; A Tichá; J Zemenová; Z Pirník; M Holubová; A Špolcová; B Mikulášková; M Blechová; D Sýkora; Z Lacinová; M Haluzík; B Železná; J Kuneš
Journal:  Int J Obes (Lond)       Date:  2015-03-16       Impact factor: 5.095

4.  Prolactin-releasing peptide affects gastric motor function in rat by modulating synaptic transmission in the dorsal vagal complex.

Authors:  Gintautas Grabauskas; Shi-Yi Zhou; Sudipto Das; Yuanxu Lu; Chung Owyang; Hylan C Moises
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

5.  The activity of prolactin releasing peptide correlates with its helicity.

Authors:  Stephanie H Deluca; Daniel Rathmann; Annette G Beck-Sickinger; Jens Meiler
Journal:  Biopolymers       Date:  2013-05       Impact factor: 2.505

6.  Endogenous prolactin-releasing peptide regulates food intake in rodents.

Authors:  Yuki Takayanagi; Hirokazu Matsumoto; Masanori Nakata; Takashi Mera; Shoji Fukusumi; Shuji Hinuma; Yoichi Ueta; Toshihiko Yada; Gareth Leng; Tatsushi Onaka
Journal:  J Clin Invest       Date:  2008-11-03       Impact factor: 14.808

7.  Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals.

Authors:  Lance J Kriegsfeld; Dan Feng Mei; George E Bentley; Takayoshi Ubuka; Alex O Mason; Kazuhiko Inoue; Kazuyoshi Ukena; Kazuyoshi Tsutsui; Rae Silver
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

8.  The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice.

Authors:  Wei Gu; Brad J Geddes; Cheng Zhang; Kevin P Foley; Alain Stricker-Krongrad
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Physiological Roles of GPR10 and PrRP Signaling.

Authors:  Garron T Dodd; Simon M Luckman
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-05       Impact factor: 5.555

10.  Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.

Authors:  Z Pirník; L Kořínková; J Osacká; B Železná; J Kuneš; L Maletínská
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.